Loading stock…

Alimentation Couche-Tard Inc. (ATD) Stock Verdict & Ratings | Investment Bastion

02Growth

Is it actually growing, and how fast?

ATDAlimentation Couche-Tard

Revenue FY26$76.5B

GROWTH RATING↗

WEAK26 / 100

REVENUE GROWTH▾SCORE

Revenue, last 3Y, CAGR+2%4

Revenue, next 1Y+14%7

Revenue, next 3Y, CAGR+4%3

Revenue, next 5Y, CAGR+2%2

EARNINGS FORECAST▾SCORE

EPS growth, FY27E-3%3

EPS growth, FY28E+7%6

EPS growth, FY29E+9%6

GROWTH ASSESSMENT

STRENGTHS

None flagged.

WATCH

Revenue is set to grow 4%/yr over the next 3 years, a little behind the market.4/10

Revenue grew 2%/yr over the last 3 years and is set to keep growing around 4%/yr.

Earnings are set to grow in step with sales (EPS about 7%/yr vs revenue 4%/yr). One year dips: EPS falls 3% next year.

WEAKNESSES

Growth is the weak spot here, trailing 74% of companies worldwide.

Over five years revenue is set to grow 2%/yr, behind 80% of companies worldwide.2/10

BOTTOM LINE

Steady Grower

Growth is a weak point here. The one thing to watch: the five-year outlook is thin.

03Price Momentum

Is the market behind it right now?

ATDAlimentation Couche-Tard

Total return Current148%

Price return Current130%

MOMENTUM RATING↗

WEAK26 / 100

SHORT-TERM RETURNS▾SCORE

1-month return-6%4

3-month return-16%2

YTD return+4%5

MID & LONG-TERM▾SCORE

% of 52-week high81%5

1-year return+7%5

3-year return+11%3

5-year return+67%6

MOMENTUM ASSESSMENT

STRENGTHS

None flagged.

WATCH

Average long-term results. Multi-year returns are middling (+11% over three years and +67% over five), roughly average for the market.

It's up 7% over the past year, but 19% below its 52-week high. That is right in line with the market.

Returns sit at the market level over the past month (-6%) and so far this year (+4%).

WEAKNESSES

The stock is underperforming over three months (-16%).

BOTTOM LINE

Falling Knife

Returns rank poorly over both the short and long run, and the price is still falling. Momentum is firmly negative — catching this is a bet against the tape, not with it. Wait for a base to form. The one thing to watch: the stock is underperforming over three months.

04Value

Are you paying a fair price for it?

Stop guessing on Couche-Tard. Get the full investment case.

Premium

$20.75/month

Billed annually at $249/year $348

✓
Stock VerdictValuation and investment strategy for 4,000+ stocks. Days of hedge fund analyst research, done in 2 minutes.
✓
RadarFind your next investment idea: top-ranked stocks across all 9 Bastion strategies.
✓
Portfolio ManagerCheck if Bastion algorithms added the stock you care about to their portfolios.

Secure via Stripe

Trusted by 1,000+ investors in our community

Loading charts…

02Growth

Is it actually growing, and how fast?

ATDAlimentation Couche-Tard

Revenue FY26$76.5B

GROWTH RATING↗

WEAK26 / 100

REVENUE GROWTH▾SCORE

Revenue, last 3Y, CAGR+2%4

Revenue, next 1Y+14%7

Revenue, next 3Y, CAGR+4%3

Revenue, next 5Y, CAGR+2%2

EARNINGS FORECAST▾SCORE

EPS growth, FY27E-3%3

EPS growth, FY28E+7%6

EPS growth, FY29E+9%6

GROWTH ASSESSMENT

STRENGTHS

None flagged.

WATCH

Revenue is set to grow 4%/yr over the next 3 years, a little behind the market.4/10

Revenue grew 2%/yr over the last 3 years and is set to keep growing around 4%/yr.

Earnings are set to grow in step with sales (EPS about 7%/yr vs revenue 4%/yr). One year dips: EPS falls 3% next year.

WEAKNESSES

Growth is the weak spot here, trailing 74% of companies worldwide.

Over five years revenue is set to grow 2%/yr, behind 80% of companies worldwide.2/10

BOTTOM LINE

Steady Grower

Growth is a weak point here. The one thing to watch: the five-year outlook is thin.

03Price Momentum

Is the market behind it right now?

ATDAlimentation Couche-Tard

Total return Current148%

Price return Current130%

MOMENTUM RATING↗

WEAK26 / 100

SHORT-TERM RETURNS▾SCORE

1-month return-6%4

3-month return-16%2

YTD return+4%5

MID & LONG-TERM▾SCORE

% of 52-week high81%5

1-year return+7%5

3-year return+11%3

5-year return+67%6

MOMENTUM ASSESSMENT

STRENGTHS

None flagged.

WATCH

Average long-term results. Multi-year returns are middling (+11% over three years and +67% over five), roughly average for the market.

It's up 7% over the past year, but 19% below its 52-week high. That is right in line with the market.

Returns sit at the market level over the past month (-6%) and so far this year (+4%).

WEAKNESSES

The stock is underperforming over three months (-16%).

BOTTOM LINE

Falling Knife

04Value

Are you paying a fair price for it?

Stop guessing on Couche-Tard. Get the full investment case.

Premium

$20.75/month

Billed annually at $249/year $348

✓
Stock VerdictValuation and investment strategy for 4,000+ stocks. Days of hedge fund analyst research, done in 2 minutes.
✓
RadarFind your next investment idea: top-ranked stocks across all 9 Bastion strategies.
✓
Portfolio ManagerCheck if Bastion algorithms added the stock you care about to their portfolios.

Secure via Stripe

Trusted by 1,000+ investors in our community

Alimentation Couche-Tard Inc.

01Key Ratings

02Growth

03Price Momentum

04Value

Stop guessing on Couche-Tard. Get the full investment case.

Premium

02Growth

03Price Momentum

04Value

Stop guessing on Couche-Tard. Get the full investment case.

Premium